The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma - Carlotta Zampieri; Kourosh Kouhmareh; Parnian Sartipdolagh; Pardis Azmoon; Richard L. Klemke; Steven L. Gonias (Journal of Biological Chemistry, 2025)